LAS41003

· Almirall, S.A.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LAS41003, covering 2010-07-09 to 2012-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis [Phase 2]